UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$351M |
| 2 |
Cisco
CSCO
|
+$313M |
| 3 |
Coca-Cola
KO
|
+$283M |
| 4 |
Estee Lauder
EL
|
+$268M |
| 5 |
TUYA
Tuya Inc
TUYA
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.16B |
| 2 |
TAL Education Group
TAL
|
+$1.92B |
| 3 |
Alibaba
BABA
|
+$1.88B |
| 4 |
Procter & Gamble
PG
|
+$640M |
| 5 |
New Oriental
EDU
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.72% |
| 2 | Healthcare | 12.81% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Coherent
COHR
$74.2B
| $7.3M | ﹤0.01% |
100,624
+22
| +0% | +$1.55K |
|
1177
HealthEquity
HQY
$8.75B
| $7.29M | ﹤0.01% |
90,564
+5,765
| +7% | +$439K |
|
|
STL
1178
DELISTED
Sterling Bancorp
STL
| $7.27M | ﹤0.01% |
293,401
-51,861
| -15% | -$1.31M |
|
1179
Qfin Holdings
QFIN
$1.61B
| $7.27M | ﹤0.01% |
+173,806
| New | +$5.29M |
|
1180
Arrowhead Research
ARWR
$12.4B
| $7.26M | ﹤0.01% |
87,661
-3,800
| -4% | -$283K |
|
1181
Curtiss-Wright
CW
$25.5B
| $7.21M | ﹤0.01% |
60,710
-3,896
| -6% | -$487K |
|
|
PINC
1182
DELISTED
Premier
PINC
| $7.21M | ﹤0.01% |
207,149
-2,310
| -1% | -$79.8K |
|
1183
Varonis Systems
VRNS
$5B
| $7.2M | ﹤0.01% |
124,990
+8,596
| +7% | +$448K |
|
|
UNVR
1184
DELISTED
Univar Solutions Inc.
UNVR
| $7.2M | ﹤0.01% |
295,276
+10,322
| +4% | +$259K |
|
1185
First Hawaiian
FHB
$3.35B
| $7.19M | ﹤0.01% |
253,773
+21,504
| +9% | +$602K |
|
|
CIT
1186
DELISTED
CIT Group Inc.
CIT
| $7.16M | ﹤0.01% |
138,740
+581
| +0.4% | +$30.5K |
|
1187
Texas Roadhouse
TXRH
$13.7B
| $7.14M | ﹤0.01% |
74,241
-3,509
| -5% | -$345K |
|
|
P
1188
Everpure Inc
P
$29.9B
| $7.13M | ﹤0.01% |
365,226
+21,242
| +6% | +$418K |
|
1189
Wintrust Financial
WTFC
$10.7B
| $7.12M | ﹤0.01% |
94,106
+5,642
| +6% | +$441K |
|
|
OLO
1190
DELISTED
Olo Inc
OLO
| $7.11M | ﹤0.01% |
190,213
-9,787
| -5% | -$311K |
|
1191
Halozyme
HALO
$12.2B
| $7.05M | ﹤0.01% |
155,295
+4,193
| +3% | +$186K |
|
1192
Bioventus
BVS
$1.19B
| $7.04M | ﹤0.01% |
+399,828
| New | +$6.44M |
|
1193
Ionis Pharmaceuticals
IONS
$9.4B
| $7.03M | ﹤0.01% |
176,341
-228,183
| -56% | -$8.94M |
|
|
BBBY
1194
DELISTED
Bed Bath & Beyond Inc
BBBY
| $7.01M | ﹤0.01% |
210,510
-14,870
| -7% | -$414K |
|
1195
Allison Transmission
ALSN
$9.82B
| $6.99M | ﹤0.01% |
175,794
-12,747
| -7% | -$542K |
|
|
VRE
1196
DELISTED
Veris Residential
VRE
| $6.94M | ﹤0.01% |
404,448
-30,750
| -7% | -$515K |
|
1197
Global Net Lease
GNL
$1.95B
| $6.92M | ﹤0.01% |
373,944
-26,093
| -7% | -$497K |
|
1198
Spire
SR
$4.85B
| $6.91M | ﹤0.01% |
95,642
+509
| +0.5% | +$37.9K |
|
1199
ICU Medical
ICUI
$4.61B
| $6.9M | ﹤0.01% |
33,550
-263
| -0.8% | -$54.1K |
|
1200
KBR
KBR
$4.8B
| $6.88M | ﹤0.01% |
180,291
+7,820
| +5% | +$310K |
|
Similar funds
UBS AM's Q2 2021 Portfolio in Review
As of Q2 2021, UBS AM held 2,827 positions worth $234B, up 3.3% from $226B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM withdrew a net $11.4B in Q2 2021, closing 76 positions and reducing 923 holdings. Its most notable exit was Seagate, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS AM opened a new position in Vanguard Short-Term Treasury ETF worth $350M.
- UBS AM's largest Q2 2021 buy was Vanguard Short-Term Treasury ETF: 5,703,693 shares worth $350M.
- UBS AM added most to Cisco in Q2 2021, an estimated $313M increase.
- UBS AM's biggest Q2 2021 reduction was Microsoft, cutting an estimated $3.16B.
- UBS AM fully exited Seagate in Q2 2021, selling an estimated $107M.
- UBS AM's ten largest holdings make up 21% of its $234B portfolio in Q2 2021.
- UBS AM opened 239 new positions and closed 76 in Q2 2021.
- UBS AM's portfolio value rose 3.3% quarter-over-quarter to $234B.
Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.